BPG is committed to discovery and dissemination of knowledge
Topic Highlight
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14087-14098
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14087
Table 3 Effect on nonvertebral/hip fracture rates (from randomized controlled trials)
Nonvertebral
Hip
Osteoporosis (without prevalent vertebral fractures)Established osteoporosis (with prevalent vertebral fractures)Osteoporosis (without prevalent vertebral fractures)Established osteoporosis (with prevalent vertebral fractures)
RaloxifeneNA●NANA
Alendronate■■NA■
RisedronateNA■NA■
IbandronateNA●NANA
Zoledronate■NA■NA
TeriparatideNA■NANA
Strontium Ranelate●■●▲
Denosumab■NA■NA


Write to the Help Desk